InflaRx IFRX
NASDAQ IFRX
$1.55 +0.02 (+1.31%)
As of: Oct 23, 2026 · 1:40 PM EDT

InflaRx (IFRX) Price to Earnings (2019 - 2020)

Updated

InflaRx's (IFRX) Price to Earnings was 573.04 for FY2022.

Analysis

InflaRx (IFRX) Price to Earnings (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,131.34 Bn 1,099.92 Bn 19.71 Bn
2 Johnson & Johnson 634.44 Bn 554.30 Bn 17.30 Bn
3 AbbVie 506.53 Bn 479.65 Bn 12.70 Bn
4 Merck 357.58 Bn 311.96 Bn 12.21 Bn
5 Novartis Ag 291.71 Bn 255.70 Bn 11.24 Bn
6 Astrazeneca 265.06 Bn 238.74 Bn 12.86 Bn
7 Amgen 238.11 Bn 193.51 Bn 7.24 Bn
8 Gilead Sciences 195.32 Bn 169.52 Bn 6.22 Bn
9 Pfizer 171.12 Bn 117.76 Bn 10.94 Bn
10 InflaRx 104.30 Mn -229.32 Mn 2.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 0.00
Jun 30, 2020 0.00
Mar 31, 2020 0.00
Dec 31, 2019 0.00
API Access

InflaRx Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=IFRX&period=max&api_key=YOUR_API_KEY